ロード中...
4CPS-014 Follow-up to recommendations about renal function monitoring in elderly patients treated with sodium-glucose co-transporter 2 inhibitors
BACKGROUND: The efficacy of sodium-glucose co-transporter 2 inhibitors (iSGLT) decrease with decreasing glomerular filtration rate. The summary of products’ characteristics recommends restriction in the use of iSGLT to patients with creatinine clearance (CrCl) >60 ml/min/1.73 m(2) and treatment s...
保存先:
| 出版年: | Eur J Hosp Pharm |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Group
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535451/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.105 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|